Factors associated with altmetric attention scores for randomized phase III cancer clinical trials.

被引：0
|
作者：
Rooney, Michael Kevin
Ludmir, Ethan B.
Fuller, Clifton Dave
Warner, Jeremy Lyle
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11014
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?
    Lowenstein, Pedro R.
    Castro, Maria G.
    CURRENT GENE THERAPY, 2009, 9 (05) : 368 - 374
  • [22] Graphical abstracts are associated with greater Altmetric attention scores, but not citations, in sport science
    Bennett, Hunter
    Slattery, Flynn
    SCIENTOMETRICS, 2023, 128 (06) : 3793 - 3804
  • [23] Unexpected results from randomized clinical trials. Or are they?
    Donnez, Jacques
    FERTILITY AND STERILITY, 2019, 112 (05) : 804 - 805
  • [24] Systematic review of time to response (TTR) in phase III metastatic cancer trials.
    Butler, Taylor
    Lopez-Trigo, Paula
    Butler, Thomas
    PHARMACOTHERAPY, 2015, 35 (05): : E92 - E93
  • [25] Current randomized phase III trials in gynecologic cancer
    不详
    ONCOLOGY-NEW YORK, 2004, 18 (13): : 1642 - +
  • [26] Racial disparities in cancer clinical trials.
    Khandwala, Pushti
    Desai, Devashish
    Das, Devika Govind
    Desai, Aakash
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [27] Looking beyond the first cycle in phase I cancer clinical trials.
    Lee, Shing Mirn
    Cheung, Ying Kuen
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Factors associated with high Altmetric Attention Score in dermatology research
    Iglesias-Puzas, Alvaro
    Conde-Taboada, Alberto
    Aranegui-Arteaga, Beatriz
    Lopez-Bran, Eduardo
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (03) : E380 - E385
  • [29] Survival and clinical outcomes of ovarian cancer patients enrolled in phase I clinical trials.
    Corr, Bradley
    Moroney, Marisa
    Sheeder, Jeanelle
    Sawyer, Brandon
    Eckhardt, S. Gail
    Behbakht, Kian
    Diamond, Jennifer Robinson
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Clinical outcomes and survival of advanced renal cancer patients in Phase I clinical trials.
    Malik, Laeeq
    Parsons, Helen
    Mahalingam, Devalingam
    Ehler, Benjamin
    Goros, Martin
    Brenner, Andrew
    Sarantopoulos, John
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345